Registry of patients with multiple sclerosis and COVID-19 infection in Saudi Arabia.

ABSTRACT:

Background

The outbreak of coronavirus disease 2019 (COVID-19) has rapidly spread and developed as a pandemic threatening global health. Patients with multiple sclerosis (MS)-an autoimmune demyelinating inflammatory disease of the central nervous system (CNS)-are predominantly treated with immunomodulatory/immunosuppressive disease-modifying therapies (DMTs), which can increase the risk of infection. Therefore, there is concern that these patients may have a higher risk of COVID-19. In response to growing concerns of neurologists and patients, this study aimed to determine the prevalence, severity, and possible complications of COVID-19 infection in patients with MS in Saudi Arabia (SA).

Methods

In this prospective cohort study, demographic and clinical data were obtained fr

SUBMITTER: Alshamrani F 

PROVIDER: S-EPMC8103739 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature